HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideyuki Saya Selected Research

Hideyuki Saya Research Topics

Disease

154Neoplasms (Cancer)
04/2024 - 02/2002
24Glioma (Gliomas)
03/2024 - 05/2003
19Glioblastoma (Glioblastoma Multiforme)
03/2024 - 10/2003
19Neoplasm Metastasis (Metastasis)
03/2022 - 02/2007
16Carcinogenesis
10/2021 - 12/2003
13Breast Neoplasms (Breast Cancer)
10/2021 - 07/2008
11Osteosarcoma (Osteogenic Sarcoma)
12/2021 - 08/2007
10Stomach Neoplasms (Stomach Cancer)
12/2023 - 06/2008
9Cholangiocarcinoma
12/2022 - 03/2010
7Brain Neoplasms (Brain Tumor)
01/2019 - 10/2009
6Inflammation (Inflammations)
10/2021 - 09/2013
6Melanoma (Melanoma, Malignant)
06/2021 - 11/2013
6Squamous Cell Carcinoma of Head and Neck
11/2019 - 02/2007
6Neurofibromatosis 1 (Neurofibromatosis Type I)
08/2010 - 03/2003
5Hypoxia (Hypoxemia)
02/2024 - 11/2002
5Carcinoma (Carcinomatosis)
01/2023 - 01/2012
5Warts (Wart)
05/2012 - 10/2002
4Adenocarcinoma
01/2023 - 09/2016
4Prostatic Neoplasms (Prostate Cancer)
01/2023 - 08/2007
4COVID-19
12/2022 - 01/2021
4Astrocytoma (Pilocytic Astrocytoma)
10/2019 - 10/2003
4Leukemia
01/2019 - 10/2009
3Urinary Bladder Neoplasms (Bladder Cancer)
04/2024 - 04/2019
3Esophageal Squamous Cell Carcinoma
06/2023 - 01/2023
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 04/2005
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 11/2013
3Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2016
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2021 - 03/2011
3Pneumonia (Pneumonitis)
01/2021 - 01/2013
3Fibrosis (Cirrhosis)
05/2018 - 02/2010
3Metaplasia
02/2017 - 10/2013
3Retinoblastoma (Glioblastoma, Retinal)
06/2012 - 11/2006
2Ascites
12/2023 - 01/2022
2Infections
06/2023 - 12/2022

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
12/2022 - 07/2003
15Phosphotransferases (Kinase)IBA
10/2021 - 12/2003
14Sulfasalazine (Azulfidine)FDA LinkGeneric
03/2021 - 10/2013
13Protein Isoforms (Isoforms)IBA
07/2022 - 01/2012
12Glutathione (Reduced Glutathione)IBA
01/2020 - 01/2012
12Cystine (L-Cystine)IBA
11/2019 - 06/2012
10Biomarkers (Surrogate Marker)IBA
04/2024 - 05/2016
10EnzymesIBA
01/2023 - 01/2005
10DNA (Deoxyribonucleic Acid)IBA
05/2022 - 05/2002
10Cisplatin (Platino)FDA LinkGeneric
03/2021 - 01/2016
10Glutamic Acid (Glutamate)FDA Link
11/2019 - 04/2015
9Reactive Oxygen Species (Oxygen Radicals)IBA
11/2017 - 03/2011
8AntioxidantsIBA
01/2021 - 03/2012
8Small Interfering RNA (siRNA)IBA
12/2018 - 07/2008
8ErbB Receptors (EGF Receptor)IBA
12/2018 - 10/2003
7Transcription Factors (Transcription Factor)IBA
01/2021 - 08/2010
7Cadherins (E-Cadherin)IBA
01/2021 - 07/2008
7Messenger RNA (mRNA)IBA
01/2020 - 03/2010
6LigandsIBA
10/2021 - 01/2014
6Neurofibromin 1 (Neurofibromin)IBA
01/2018 - 07/2003
5Epithelial Cell Adhesion MoleculeIBA
12/2023 - 11/2011
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 03/2012
5Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 02/2002
5Hyaluronic Acid (Hyaluronan)IBA
01/2017 - 08/2003
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2015 - 06/2008
5Cyclin-Dependent Kinase Inhibitor p16IBA
06/2012 - 11/2006
4Antineoplastic Agents (Antineoplastics)IBA
04/2024 - 08/2004
4AntibodiesIBA
06/2023 - 01/2016
4Amino AcidsFDA Link
01/2023 - 10/2012
4CytokinesIBA
10/2021 - 05/2009
4Celecoxib (Celebrex)FDA Link
01/2021 - 01/2017
4AntiportersIBA
11/2019 - 09/2018
4Trastuzumab (Herceptin)FDA Link
01/2018 - 05/2008
4Monoclonal AntibodiesIBA
01/2016 - 08/2003
3Circulating Tumor DNAIBA
06/2023 - 01/2023
3GemcitabineFDA Link
01/2023 - 03/2021
3RNA (Ribonucleic Acid)IBA
01/2023 - 01/2017
3Neutralizing AntibodiesIBA
12/2022 - 01/2021
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2022 - 12/2017
3Oxygen (Dioxygen)IBA
01/2022 - 01/2018
3PeriostinIBA
06/2021 - 01/2015
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2021 - 01/2017
3LipidsIBA
01/2021 - 10/2012
3MicellesIBA
10/2019 - 01/2016
3Histones (Histone)IBA
01/2019 - 05/2013
3Epidermal Growth Factor (EGF)IBA
12/2018 - 01/2014
3human ERBB2 proteinIBA
07/2018 - 06/2012
3Indicators and Reagents (Reagents)IBA
01/2018 - 05/2016
3spasmolytic polypeptideIBA
02/2017 - 10/2013
3Dinoprostone (PGE2)FDA Link
03/2016 - 03/2010
3Progesterone Receptors (Progesterone Receptor)IBA
12/2015 - 06/2012
3Estrogen ReceptorsIBA
12/2015 - 06/2012
3Pyruvate KinaseIBA
08/2014 - 03/2012
3GTPase-Activating Proteins (GTPase-Activating Protein)IBA
11/2005 - 07/2003
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
08/2005 - 10/2002
2protoporphyrin IXIBA
03/2024 - 01/2021
2Androgen Receptors (Androgen Receptor)IBA
10/2023 - 08/2007
2BoronIBA
01/2023 - 01/2012

Therapy/Procedure

40Therapeutics
04/2024 - 05/2003
20Drug Therapy (Chemotherapy)
02/2024 - 07/2009
6Transplantation
03/2022 - 02/2010
5Radiotherapy
01/2023 - 01/2016
4Aftercare (After-Treatment)
01/2016 - 04/2005
3Immunotherapy
04/2023 - 01/2018
2Neoadjuvant Therapy
02/2024 - 06/2023
2Castration
01/2023 - 05/2016